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Purpose: This study evaluated the clinical manifestations of and risk 
factors for pituitary insufficiency in children and adolescents with 
Rathke’s cleft cysts. 
Methods: Forty-four patients with Rathke’s cleft cysts younger than 19 
years who visited Seoul National University Children’s Hospital between 
January 1995 and September 2009 were enrolled. Rathke’s cleft cysts 
were confirmed histologically through an operation in 15 patients and 
by brain magnetic resonance imaging (MRI) in 29 patients. The clinical, 
hormonal, and imaging features were reviewed retrospectively. 
Results: The clinical presentation of symptomatic patients was as follows: 
headache (65%), endocrinopathy (61%), and visual disturbance (19%). 
Endocrinopathy included central precocious puberty (18%), diabetes 
insipidus (14%), general weakness (11%), and decreased growth velocity 
(7%). After surgery, hyperprolactinemia resolved in all patients, but 
growth hormone insufficiency, hypothyroidism, and diabetes insipidus 
did not improve. Pituitary insufficiency except gonadotropin abnormality 
correlated significantly with severe headache, visual disturbance, general 
weakness, and cystic size. Suprasellar extension of cysts and high signals 
in the T2-weighted image on brain MRI were related to hypothyroidism, 
hypocortisolism, and diabetes insipidus. Multivariable linear regression 
analysis showed that only general weakness was a risk factor for pituitary 
insufficiency (R
2=0.549). 
Conclusion: General weakness is a risk factor for pituitary insufficiency 
in patients with Rathke’s cleft cysts. When a patient with a Rathke’s 
cleft cyst complains of general weakness, the clinician should evaluate 
pituitary function and consider surgical treatment.
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Introduction
Rathke’s cleft cyst (RCC) is a non-neoplastic lesion lined by a 
single layer of epithelium in the sellar and suprasellar regions and 
is often discovered incidentally
1-3). RCC has been reported rarely in 
children and adolescents, and may not be discovered clinically until 
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the age of 50-60 years
4). Rathke’s pouch is a component of the 
developmental craniopharyngeal duct that gives rise to the anterior 
lobe, pars intermedia, and pars tuberalis of the pituitary gland, 
and it normally closes in early fetal development. However, failure 
of this pouch to regress upon formation of the adenohypophysis 
and neurohypophysis can produce an RCC
2, 3, 5). The incidence 
of RCC in children and adolescents is unknown, but Teramoto 
et al
6) reported that an RCC was discovered in 1.7% of routine 
autopsies of people aged 10-29 years and in 13-22% of autopsies of 
older people. Although it is generally believed that a symptomatic 
RCC occurs rarely, the most common clinical manifestations 
include headache, visual disturbance, and variable endocrine 
insufficiencies. Less frequent presentations include pituitary 
apoplexy, abscess formation, and meningitis.  A few cases have been 
reported of children and adolescents with a symptomatic RCC 
who showed delayed puberty, central precocious puberty, growth 
retardation, and menstrual abnormalities
1, 2, 4, 7-11). Treatment of an 
RCC generally includes regular brain magnetic resonance imaging 
(MRI). If the RCC becomes symptomatic or its size increases, 
surgical treatment is recommended. The transsphenoidal approach 
remains the preferred method for surgical drainage of such lesions, 
because cystic aspiration or partial resection is usually enough to 
treat a symptomatic RCC and the the postoperative recurrence is 
rare
3, 7-9).
With the increased use of brain MRI, more RCCs are being 
discovered. However, it is difficult to devise a strategy for treatment 
because a symptomatic RCC is rare in children and adolescents, 
and there are no reports of the clinical manifestations related 
to RCC, particularly endocrine dysfunction, in children and 
adolescents. In this study, we aimed to devise a strategy for the 
treatment of children and adolescents with an RCC by comparing 
the clinical manifestations, radiological features, hormonal 
changes, and risk factors of endocrine dysfunction in symptomatic 
patients treated surgically with asymptomatic patients whose RCC 
was discovered by chance. 
Materials and methods
1. Patients
Forty-four patients (22 males and 22 females) aged from 0 to 
18 who had visited Seoul National University Children’s Hospital 
from January 1995 to September 2009 and who were treated for 
an RCC were included. In 15 patients (8 males and 7 females), 
the RCC was confirmed histologically in a sample taken during 
surgery, and 29 patients (14 males and 15 females) were diagnosed 
by brain MRI examination. Thirty-one patients (16 males and 15 
females) showed symptoms, and 13 subclinical patients (6 males 
and 7 females) were found by chance. The median age for the 
entire group was 10.1 years, and the youngest patient was 1 month 
old. The median duration from the appearance of symptoms to 
diagnosis was 8.7 months, and one patient was diagnosed 223 
months after the appearance of symptoms. The median follow-
up period was 15.6 months; patients were included who could be 
traced and examined for a minimum of 1 month to a maximum 
of 95 months (Table 1).
2. Methods
Using retrospective examination of the patients’ medical records, 
age, sex, height, weight, bone age, sexual maturity rating, growth 
velocity, date of symptom appearance, and follow-up interval were 
recorded.
In patients who showed symptoms, the symptoms were classified 
into endocrine, neurological, ophthalmic, and other fields. The 
diagnosis through brain MRI examination was limited to RCC 
diagnosed by two or more diagnostic imaging specialists from two 
or more times of imaging sessions. The cyst’s location, size, shape, 
presence of calcification, hemorrhage, and peripheral rim contrast 
enhancement were evaluated. The signal intensity of T1- and T2-
weighted images was classified into high, equal or low.
Peripheral blood samples were collected and the following basal 
hormone levels were measured in the plasma at time of diagnosis 
or before and after the operation using immunoradiometric 
assay methods. The concentration of growth hormone (GH), 
insulin like growth factor-1 (IGF-1), free thyroxine (free T4), 
triiodothyronine, thyroid stimulating hormone (TSH), cortisol 
and adrenocorticotropic hormone (ACTH) (blood sampled in the 
morning), luteinizing hormone (LH), follicle stimulating hormone 
(FSH), estradiol or testosterone, and prolactin were measured. A 
pituitary function test was performed after surgery. Other tests 
were performed; GH stimulation test using L-Dopa and clonidine 
or insulin tolerance test, thyrotropin releasing hormone (TRH) 
stimulation test, gonadotropin releasing hormone (GnRH) 
stimulation test, low-dose ACTH stimulation test. To assess the 
deficiency in antidiuretic hormone (ADH), urine output per hour, 
serum and urine osmotic pressure, urine specific gravity, and 
electrolytes were measured, or some patents were confirmed with 
water deprivation test. The medicines to treat the endocrinological 
disorders such as GH, thyroid hormone, cortisol, sex hormone, and 
ADH, were recorded in the follow-up examination.
Hypopituitarism was diagnosed as follows. GH deficiency was 
defined as a maximum GH concentration of less than 10 ng/mL in 
two or more GH stimulation tests using agents such as clonidine, Korean J Pediatr 2010;53(7):759-765 • DOI: 10.3345/kjp.2010.53.7.759    761
L-Dopa, and glucagon, or a maximum GH concentration in 
the insulin tolerance test of less than 3 ng/mL
12). A standard 
deviation score of basal IGF-1 concentration less than -2.0
13) and 
a growth velocity of less than 4 cm/year was separately classified 
as suspected GH deficiency. The combination of a decrease 
in both of free T4 and TSH was classified as suspected TSH 
deficiency, and the absence of an increase in TSH concentration 
in the TRH stimulation test was classified as TSH deficiency
14). 
A morning cortisol level of less than 5 µg/dL and no increase in 
ACTH level was classified as suspected ACTH deficiency, In the 
ACTH stimulation test performed 2 weeks or more after surgery, 
an increase in cortisol level of less than 7 µg/dL or a maximum 
of less than 18 µg/dL was defined as ACTH deficiency
15). 
Hypogonadotropic hypogonadism was defined as an LH level in 
GnRH stimulation test for females with bone age of more than 13 
years and males with bone age of more than 15 years of less than 
5 mIU/mL. In patients with sexual maturity rating of more than 
Tanner II in the physical examination, an LH level more than the 
maximum 5 mIU/mL in GnRH stimulation test for girls younger 
than 8 years and boys younger than 9 years was diagnosed as 
central precocious puberty
16). Hyperprolactinemia was defined a 
serum prolactin level more than 25 ng/mL.
3. Statistics
The patients’ age, sex and clinical symptoms at diagnosis were 
represented as the median, minimum, and maximum, and these 
were analyzed using frequency analysis. Fisher’s exact test was 
used to analyze the results of brain MRI examination according 
to symptoms and treatment. Comparison of the size of the cysts 
was made using the Mann-Whitney U test. Fisher’s exact test was 
used to evaluate dysfunction of each pituitary hormone according 
to clinical symptoms and MRI findings. The extent of hormone 
dysfunction in relation to the size of the cyst was compared by 
one-way ANOVA. Spearman’s correlation analysis and univariate 
and multivariate linear regression analysis were used to identify 
relationship between clinical symptoms, MRI findings, and 
hormone dysfunction. The data were analyzed using SPSS version 
17.0 for Windows (SPSS Inc, Chicago, IL, USA), and a P value less 
than 0.05 was considered significant.
Results
1. Clinical symptoms at diagnosis 
The symptoms of RCC included 20 patients with headache, 
19 patients with endocrine dysfunction, and six patients with 
decreased visual acuity and visual field defects. Headache was 
accompanied mainly by vomiting. Headache was persistent 
and worsened in the operation group, while it was temporarily 
continued in most cases. The non-surgical group reported less 
frequent headaches but these were not accompanied by vomiting. 
The patients in the operation group showed most endocrine 
symptoms except for precocious puberty. In the operation group, 
eight patients had precocious puberty, six patients had diabetes 
insipidus, five patients had general weakness, and three patients 
had decreased growth velocity of less than 4 cm/year. All patients 
with ophthalmic problems were operated. Three patients had 
bitemporal hemianopsia and three patients had decreased visual 
acuity. 13 patients with RCC were found by chance in a brain 
Table 1. Characteristics of Patients with Rathke’s Cleft Cysts
Patients  N=44
Age (year)
Sex
Male (%)
Female (%)
Duration of symptoms (month)
Duration of follow-up (month)
Symptoms at presentation
Symptomatic (%)
Non-synptomatic (%)
Treatment
Surgical management (%)
Conservative management (%)
10.1 (0.1-18.2)*
22 (50.0)
22 (50.0)
8.7 (0.1-223)*
15.6 (0.1-95)*
31 (79.5)
13 (29.5)
15 (34.1)
29 (65.9)
*median (range)
Table 2. Clinical Presentations of Patients with Rathke’s Cleft Cysts
Symptoms at presentation
Operative
(N=15) (%)
Conservative
(N=29) (%)
Enocrinologic 
Polydipsia, Polyuria, and Nocturia
Delayed puberty
Central Precocious puberty
Decreased growth velocity
Menstrual problem
Hyperprolactinemia
General weakness
Neurologic 
Persistent aggravating headache
Intermittent or transient headache
Headache with vomiting
Heache with dizziness
Opthalmologic
Visual filed defect
Decreased visual activity
Others
Weight loss
Incidenatal (asymptomatic)
Seizure
Developmental delay
Congenital anomalies
Head trauma
6 (40.0)
2 (13.3)
2 (13.3)
3 (20.0)
0 (  0.0)
3 (20.0)
5 (33.3)
10 (66.7)
0 (  0.0)
7 (46.7)
1 (  6.7)
3 (20.0)
3 (20.0)
2 (13.3)
0 (  0.0)
0 (  0.0)
0 (  0.0)
2 (13.3)
0 (  0.0)
0 (  0.0)
6 (20.7)
0 (  0.0)
1 (  3.4)
2 (  6.9)
0 (  0.0)
1 (  3.4)
9 (31.0)
0 (  0.0)
1 (  3.4)
0 (  0.0)
0 (  0.0)
0 (  0.0)
3 (10.3)
5 (17.2)
2 (  6.9)
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MRI examination performed because of epilepsy, developmental 
disorder, congenital malformation and head injury. Two of these 
patients were operated operated on for asymptomatic pituitary 
macroadenoma (Table 2).
2. Changes in pituitary functions before and after the 
operation 
Pituitary hormone dysfunction was compared from before 
to after the operation. Before the operation, three patients had 
suspected GH deficiency, six had suspected TSH deficiency, seven 
had suspected ACTH deficiency, two had LH/FSH deficiency, 
three had hyperprolactinemia, and six had diabetes insipidus. 
The pituitary function test after the operation showed that seven 
patients had GH deficiency, eight had TSH deficiency, nine had 
ACTH deficiency, six had LH/FSH deficiency, and nine had 
diabetes insipidus. Hyperprolactinemia was resolved in all patients 
(Table 3).
3. Analysis of the relationship between clinical symptoms, 
radiological characteristics, and pituitary hormone 
insufficiency 
The relationships between the secretion disorder for each 
pituitary hormone and several factors were analyzed at the 
presentation of RCC. Mild headache was not significantly related 
to pituitary hormone dysfunction except one with precocious 
puberty. Severe headache correlated with TSH deficiency (P<0.001), 
GH deficiency (P=0.017), ACTH deficiency (P=0.003), and 
ADH deficiency (P=0.004). Decreased visual acuity or a visual 
field defect was related to ACTH deficiency (P=0.007) and TSH 
deficiency (P=0.047). All patients with general weakness had TSH 
deficiency (P<0.001) and showed other pituitary hormone disorders 
except for precocious puberty. The size of the cyst was related 
to deficiencies in all hormones except LH/FSH, and was closely 
related to GH deficiency (P<0.001) and TSH deficiency (P<0.001). 
The Cyst closer to the suprasellar area were significantly associated 
with TSH deficiency (P=0.011), ACTH deficiency (P=0.025), and 
ADH deficiency (P=0.013). Hyperintensity of the RCC in T1- and 
T2-weighted images correlated significantly with TSH deficiency 
(P<0.001) and ADH deficiency (P=0.003) (Table 4).
Table 3. Changes in Pituitary Dysfunction from Before to After Surgical 
Treatment
Pituitary hormone
At presentation
(N=15) (%)
Postoperative state
Improved
(%)
†
Persistent
(%)
†
New onset
(N=15) (%)
GH deficiency
TSH deficiency
ACTH deficiecny
LH/FSH deficiency
Hyperprolactinemia
Diabetes insipidus 
3 (20.0)*
6 (40.0)*
7 (46.7)*
2 (13.4)
3 (20.0)
6 (40.0)
0 (    0.0)
0 (    0.0)
3 (  42.9)
0 (    0.0)
3 (100.0)
0 (    0.0)
3 (100.0)
6 (100.0)
4 (  57.1)
2 (100.0)
0 (    0.0)
6 (100.0)
4 (26.7)
2 (13.3)
5 (33.3)
4 (26.7)
0 (  0.0)
3 (20.0)
*These are suggestive hormone insufficiency, not confirmed hormone 
provocation test
†The results are on the basis of counts at presentation
Table 4. Correlation between Pituitary Hormone Insufficiency, Clinical and Radiological Findings
Variable parameters GHD THD HPAD CPP GND HPL DI
Symptom & Sings
Mild headache (N=8)
Severe headache (N=12)
Visual disturbance (N=6)
General weakness (N=5)
Brain MRI findings
Cystic size (mm, mean±SD)
Location of cyst
Intrasellar
Intra &  suprasellar
Suprasellar
T1-weighted (N=44)
Hypointensity
Isointendity
Hyperintensity
T2-weighted (N=37)
Hypointensity
Isointendity
Hyperintensity
0
3*
1
1
23.7±5.5
†
0
2
1
0
0
3*
0
0
3
0
7
†
3*
5
†
23.2±10.9
†
0
5*
2
0
0
7
†
1
0
6
0
6*
4*
3*
16.8±8.3*
1
5*
2
2
1
5
0
1
6*
1
0
1
0
7.1±4.3
6
1
1
6*
2
0
3
0
1
0
2
1
2*
17.5±10.6
0
2
0
0
0
2
0
0
2
0
3
2
3*
16.6±11.0*
1
3
1
0
1
4
0
1
3
0
5*
2
3*
22.0±13.0*
0
3
3*
0
1
5*
0
0
6*
*P<0.05, 
†P<0.001
Abbreviations: GHD, growth hormone deficiency; THD, hypothyroidism; HPAD, hypocortisolism; CPP, central precocious puberty; GND, hypogonadism; HPL, 
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4. Analysis of factors causing pituitary dysfunction in 
patients with RCCs 
Analysis of the relationships between various clinical symptoms, 
radiological findings, and pituitary hormone dysfunction showed 
significant relationships between pituitary hormone dysfunction 
and visual field defect, general weakness, location of the cyst, 
and high signal intensity of T2-weighted image. However, after 
controlling for the mutual relationships between variable, only 
general weakness was significantly relation to pituitary hormone 
dysfunction (R
2=0.549, P=0.045) (Table 5).
Discussion
RCC is a non-neoplastic remnant of Rathke’s pouch and is 
mostly asymptomatic. The etiology of symptom appearance is not 
known precisely. In studies of adults, the cause is assumed to be the 
change in the cyst size because of an imbalance between secretion 
and absorption of the contents of the cyst, leakage, intracystic 
hemorrhage, or infection
2, 14, 17). In this study, the clinical symptoms 
were headache in 20 patients (65%), endocrinopathy in 19 patients 
(61%), and visual disturbance in six patients (19%). Patients whose 
headaches were frequent and worsening or were accompanied by 
nausea and vomiting had pituitary insufficiency and tendency to 
need surgical treatments. 
The interesting aspect of the endocrinopathy was the high 
frequency of early puberty (eight patients, 26%). All children 
who showed signs of early puberty were positive in the GnRH 
stimulation test. Of the seven girls with central precocious puberty, 
four were being treated with a GnRH agonist. Cases of precocious 
puberty in children in associated with RCC are reported rarely
18-20). 
One case study
20) reported that treatment with a GnRH agonist 
resolved the symptoms of early puberty without changing the cyst. 
The relationship between central precocious puberty and RCC 
is not clear. Our comparison between patients with precocious 
puberty and secretory dysfunction of other pituitary hormones 
showed several differences. The patients with precocious puberty: 1) 
had smaller cysts, 2) had cysts mainly in intrasellar sites, 3) showed 
hypointensity of the cysts in T1- and T2-weight enhanced images, 
4) had no additional insufficiencies of pituitary hormones before 
and after the operation, 5) had improved clinical characteristics 
after treatment with a GnRH agonist without changes of the cyst. 
It is assumed that the precocious puberty associated with RCC is 
caused by a different mechanism than that causing dysfunction 
of other pituitary hormones. RCC with precocious puberty 
may be an independent pituitary disease or another feature of 
asymptomatic RCC. Karavitaki et al
20) and Bader et al
21) found 
corticotrophic pituitary adenoma in adult patients with an RCC 
accompanied by Cushing’s syndrome; these patients showed 
considerable hypersecretory dysfunction associated with the 
RCC. It is possible that precocious puberty is caused by an RCC 
is association with a gonadotropic adenoma. We did not perform 
immunohistochemical staining to identify the hormone-secreting 
cells after the operation in our patients and cannot confirm 
whether this is true.
Several studies show that the patients with RCC may develop 
additional clinical symptoms and endocrinopathy after the 
operation
2, 4, 8, 9, 22). In this study, the headache and visual 
disturbances experienced by all 15 patients stopped after the 
operation; this is a high rate of improvement compared with case 
reports of adults in Korea and other countries. Several studies
9, 
14, 23, 24) have shown improvements in visual field defects in 59-
100% of patients and in headache in 40-100% of patients. Kim 
et al
8) reported that visual acuity, visual field defects, and headache 
improved in 68%, 59%, and 93% of patients, respectively. 
However, in contrast to the clinical symptoms, the resolution of the 
endocrine dysfunction was less successful after the operation. Only 
20% of patients showed improvement in endocrine dysfunction 
and some showed a worsened condition. Twenty percent of 
patients showed a deficiency in all pituitary hormones. The extent 
of changes in hormones differed between hormones. For example, 
hyperprolactinemia improved in all patients after the operation and 
no patients developed a new deficiency, whereas deficiencies in GH, 
TSH, and ADH continued or worsened in all patients. Usually, 
ACTH deficiency was evident in a high proportion of patients 
(seven patients, 47%) before the operation; three patients showed 
improvement, but five other patients developed a new deficiency 
after the operation. These postsurgical results are worse than those 
in some reports showing that 3.6-30% of patients develop a new 
hormone deficiency
3, 8, 9, 11). However, other studies have reported 
Table 5. Factors Reflecting Pituitary Dysfunction in Patients with 
Rathke’s Cleft Cysts
Risk factors
Univariate analysis Multivariate analysis
P value R
2 P value R
2
Symptom & Sings
Headache
Visual disturbance 
General weakness 
Brain MRI findings
Cyst size
Cyst shape
Cyst location
T1-weighted
T2-weighted
0.136
0.021
0.010
0.282
0.696
0.002
0.282
0.012
0.149
0.168
0.311
0.145
0.001
0.240
0.082
0.202
0.233
0.205
0.045
0.420
0.882
0.372
0.935
0.072
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similar rates to those in our study: 14-20% of patients developing a 
pituitary hormone dysfunction after the operation
3, 8, 24, 25) and 42.9-
100% recovering from hyperprolactinemia
4, 8, 11, 26, 27).
In patents with a symptomatic RCC, the clinical characteristics 
may worsen later or improve spontaneously, and it is difficult 
to predict their influences on the pituitary. We compared the 
secretory dysfunction in our patients according to clinical 
symptoms and MRI findings in the diagnosis. Severe headache, 
decreased visual acuity, visual field defects, and a larger size and 
suprasellar location of the cyst were related to hypopituitarism but 
precocious puberty and hypogonadism were not. General weakness 
showed the highest correlation with secretory dysfunction of all 
pituitary hormones, in particularly, TSH deficiency (P<0.001), 
but was not related to precocious puberty. A larger cyst was related 
to GH deficiency and TSH deficiency (P<0.001 for each). The 
closer the location of the cyst to the intrasellar area, the lower the 
frequency of TSH deficiency and ACTH deficiency. The closer the 
location of the suprasellar area, the higher the frequency of ADH 
deficiency. Univariate linear analysis showed a higher correlation 
between the location of the cyst and pituitary dysfunction, 
including gonadotropic hormone deficiency, than the cyst size. The 
high signal intensity in T1- and T2-weighted images was related 
to TSH deficiency and ADH deficiency. These results are similar 
to those of Nishioka et al
23) who reported the a higher frequency of 
dysfunction of the anterior and posterior pituitary glands in cysts 
with a high signal intensity in T1-weighted images. However, after 
excluding the correlation between several related factors in our 
study, multivariate analysis showed that general weakness was the 
only significant risk factor for pituitary dysfunction (R
2=0.549, 
P=0.045). This suggests that a child or adolescent with an RCC 
who represents with general weakness should be checked carefully 
to determine whether active treatment is needed.
Our study has some limitation. We did not perform pituitary 
stimulation tests in all patients before the operation, only in those 
with a suspected deficiency in GH, TSH, or ACTH. Our study 
was also a retrospective cross-sectional design with small numbers 
of patients. Follow-up studies of larger groups are needed to 
understand the changes during adulthood.
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